Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A4HTR9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 69 | 71 | PF00675 | 0.574 |
CLV_PCSK_FUR_1 | 67 | 71 | PF00082 | 0.560 |
CLV_PCSK_KEX2_1 | 69 | 71 | PF00082 | 0.574 |
CLV_PCSK_PC7_1 | 65 | 71 | PF00082 | 0.573 |
DOC_PP2B_LxvP_1 | 9 | 12 | PF13499 | 0.538 |
LIG_14-3-3_CanoR_1 | 26 | 34 | PF00244 | 0.415 |
LIG_14-3-3_CanoR_1 | 48 | 56 | PF00244 | 0.391 |
LIG_Actin_WH2_2 | 32 | 50 | PF00022 | 0.297 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.607 |
LIG_EH_1 | 60 | 64 | PF12763 | 0.354 |
LIG_FHA_1 | 4 | 10 | PF00498 | 0.566 |
LIG_FHA_2 | 99 | 105 | PF00498 | 0.398 |
LIG_LIR_Apic_2 | 55 | 59 | PF02991 | 0.351 |
LIG_LIR_Gen_1 | 60 | 71 | PF02991 | 0.369 |
LIG_LIR_Nem_3 | 50 | 56 | PF02991 | 0.387 |
LIG_LIR_Nem_3 | 60 | 66 | PF02991 | 0.377 |
LIG_LIR_Nem_3 | 95 | 100 | PF02991 | 0.356 |
LIG_Pex14_2 | 76 | 80 | PF04695 | 0.375 |
LIG_SH2_STAT5 | 100 | 103 | PF00017 | 0.361 |
LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.378 |
LIG_SH3_1 | 56 | 62 | PF00018 | 0.349 |
LIG_SH3_3 | 56 | 62 | PF00018 | 0.349 |
LIG_SH3_3 | 9 | 15 | PF00018 | 0.536 |
LIG_TYR_ITIM | 42 | 47 | PF00017 | 0.363 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.584 |
MOD_CK2_1 | 98 | 104 | PF00069 | 0.359 |
MOD_N-GLC_1 | 17 | 22 | PF02516 | 0.342 |
MOD_NEK2_1 | 16 | 21 | PF00069 | 0.593 |
MOD_NEK2_1 | 25 | 30 | PF00069 | 0.523 |
MOD_NEK2_1 | 47 | 52 | PF00069 | 0.342 |
MOD_PKA_2 | 25 | 31 | PF00069 | 0.415 |
MOD_PKA_2 | 47 | 53 | PF00069 | 0.430 |
MOD_Plk_1 | 17 | 23 | PF00069 | 0.603 |
TRG_ENDOCYTIC_2 | 44 | 47 | PF00928 | 0.304 |
TRG_ER_diArg_1 | 66 | 69 | PF00400 | 0.380 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4J8M9 | Bodo saltans | 65% | 100% |
A0A1X0NMV9 | Trypanosomatidae | 84% | 100% |
A0A3S5H6A4 | Leishmania donovani | 100% | 100% |
A0A422NE39 | Trypanosoma rangeli | 85% | 100% |
A4H5H8 | Leishmania braziliensis | 99% | 100% |
D0A978 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 82% | 67% |
E9AMK2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
V5B330 | Trypanosoma cruzi | 84% | 100% |